PNU-177864是一种口服活性、高选择性的多巴胺D3受体拮抗剂，其通过在体内诱导磷脂代谢变化，展现出显著的抗精神分裂症活性。
/
-25~-15℃避光保存，有效期3年。
[1] Basova L, Najera JA, Bortell N, Wang D, Moya R, Lindsey A, Semenova S, Ellis RJ, Marcondes MCG. Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: Implications to HIV infection. PLoS One. 2018 Jun 26;13(6):e0199861. doi: 10.1371/journal.pone.0199861. PMID: 29944719; PMCID: PMC6019408.
[2]Vonderfecht SL, Stone ML, Eversole RR, Yancey MF, Schuette MR, Duncan BA, Ware JA. Myopathy related to administration of a cationic amphiphilic drug and the use of multidose drug distribution analysis to predict its occurrence. Toxicol Pathol. 2004 May-Jun;32(3):318-25. doi: 10.1080/01926230490431763. PMID: 15204973.
